Skip to Main Content

Latest Original Research

CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
John J Sim and others
Background and Hypothesis We assessed disease progression among patients with immunoglobulin A nephropathy (IgAN) and characterized factors associated with risk for adverse outcomes. Methods A retrospective longitudinal cohort (2000–2022) study of ...
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
Bjørn O Eriksen and others
Background and hypothesis High glomerular filtration rate (GFR) is generally regarded as beneficial but has been associated with cardiovascular disease (CVD) and all-cause mortality in epidemiological studies. However, these investigations may have ...
Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients
Frederik Haupenthal and others
Background After kidney transplantation adherence to immunosuppressive medication is crucial for graft survival and its assessment requires valid measurements. The Basel-Assessment-of-Adherence-to-Immunosuppressive-Medications-Scale (BAASIS) is a ...
Acute Kidney Injury in Very Old Patients - Incidence, Severity, Risk Factors and Short-Term Outcomes
Stefan Herget-Rosenthal and others
Background and hypothesis Although old age is a risk factor for acute kidney injury (AKI), data on AKI in individuals ≥80 years is limited. We aimed to provide data on AKI incidence, severity, and outcomes, to identify risk factors of AKI and 30-day ...
Plasma Trimethylamine N-oxide Concentration and All-Cause Mortality in Kidney Transplant Recipients
Manuela Yepes-Calderón and others
Background and hypothesis Trimethylamine N-oxide (TMAO) is a pro-atherosclerotic molecule produced by intestinal microbiome. TMAO has been linked to increased mortality risk in chronic kidney disease, but its effect in kidney transplant recipients ...

Latest Reviews

Chronic lung diseases and kidney disease: pathophysiology and management
Silvia De Rosa and others
Acute kidney injury (AKI) is a critical complication in patients with chronic lung diseases (CLD), particularly during acute exacerbations. This review focuses on the pathophysiological mechanisms linking CLD to AKI and highlights key clinical ...
Genome-wide donor recipient non-HLA mismatch and graft loss
Josef Pickl and others
HLA-matching between donor (D) and recipient (R) is routinely performed in kidney allocation to optimize allograft survival but explains only a moderate variability of these outcomes. Recent findings suggest that donor to recipient mismatches ...
Cardiovascular Involvement in ANCA-associated Vasculitis
Ahmad Sarmad and others
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic necrotizing vasculitis with significant cardiovascular involvement, primarily manifesting in granulomatosis with polyangiitis, microscopic polyangiitis, and ...
Maintaining kidney health in aging societies: a JSN and ERA call to action
Alberto Ortiz and others
Chronic kidney disease (CKD) is the fastest growing cause of death, expected to become the fifth global cause of death and the third in some countries with long life expectancy, such as Japan and Spain by 2050. This reflects societal aging, as ...
ABCDE to identify and prevent chronic kidney disease: a call to action
Charles J Ferro and others
Kidney disease is a global health priority affecting >850 million people worldwide. This number is projected to increase over the coming decades given the increasing prevalence of diabetes, hypertension and obesity and the aging population. ...

Impact Factor
4.8

Impact Factor Rank
Transplantation 5 out of 31
Urology & Nephrology 15 out of 126

5-year IF
5.0

CiteScore
10.1

CiteScore Rank
Nephrology 7 out of 81
Transplantation 5 out of 54

ERA Journal Club e-seminars

The ERA Journal Club e-seminars aim to initiate an open discussion among the nephrology community on how the results obtained in the recent trials can be applied to the needs of patients.

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial 

February 27, 2025
From 5:00 to 5:45 PM (CET)

Register here

 

 

Author Videos

Video is a dynamic feature of the journal, providing a multimedia experience for NDT readers. With our tools and guidelines, authors present their article in brief, easy to watch videos that cover recent reviews, reports, original research, and more.

Watch more NDT author videos

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close